Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
ReachMD ReachMD
855 subscribers
1 view
0

 Published On Apr 28, 2024

Guest: Sami Khella, MD


Guest: Marcia Waddington-Cruz, MD, PhD




Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.

show more

Share/Embed